Disc Medicine Inc (IRON)
45.07
+0.72
(+1.62%)
USD |
NASDAQ |
Jun 28, 16:00
45.06
-0.02
(-0.03%)
After-Hours: 20:00
Disc Medicine Cash from Investing (Quarterly): -0.067M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.067M |
| December 31, 2023 | -0.003M |
| September 30, 2023 | -0.045M |
| June 30, 2023 | -0.012M |
| March 31, 2023 | -0.029M |
| December 31, 2022 | -0.012M |
| September 30, 2022 | -0.019M |
| June 30, 2022 | -0.02M |
| Date | Value |
|---|---|
| March 31, 2022 | -0.10M |
| December 31, 2021 | -0.007M |
| September 30, 2021 | -0.061M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.022M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.10M
Minimum
Mar 2022
--
Maximum
Dec 2020
-0.0305M
Average
-0.02M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | -14.04M |
| Alnylam Pharmaceuticals Inc | -67.62M |
| Marinus Pharmaceuticals Inc | 20.88M |
| Rocket Pharmaceuticals Inc | 35.03M |
| Regenxbio Inc | 13.18M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -33.60M |
| Cash from Financing (Quarterly) | 15.90M |
| Free Cash Flow | -71.72M |
| Free Cash Flow Per Share (Quarterly) | -1.357 |
| Free Cash Flow Yield | -6.70% |